Achieved serum magnesium concentrations and occurrence of delayed cerebral ischaemia and poor outcome in aneurysmal subarachnoid haemorrhage

Background: Magnesium therapy probably reduces the frequency of delayed cerebral ischaemia (DCI) in subarachnoid haemorrhage (SAH) but uncertainty remains about the optimal serum magnesium concentration. We assessed the relationship between serum magnesium concentrations achieved with magnesium sulp...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2007-07, Vol.78 (7), p.729-731
Hauptverfasser:	Dorhout Mees, Sanne M, van den Bergh, Walter M, Algra, Ale, Rinkel, Gabriel J E
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aneurysms Biological and medical sciences Brain Ischemia - etiology Brain Ischemia - prevention & control Cardiovascular system DCI delayed cerebral ischaemia Female Humans Intracranial Aneurysm - complications Intracranial Aneurysm - drug therapy Long term Magnesium Magnesium - blood Magnesium Sulfate - pharmacokinetics Magnesium Sulfate - therapeutic use Male Medical imaging Medical sciences Middle Aged Neurology Odds Ratio Patients Pharmacology. Drug treatments Prognosis Regression Analysis SAH subarachnoid haemorrhage Subarachnoid Hemorrhage - complications Subarachnoid Hemorrhage - drug therapy Time Factors Treatment Outcome Vascular diseases and vascular malformations of the nervous system Vasodilator agents. Cerebral vasodilators
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!